BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1851548)

  • 61. Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour.
    Natrajan R; Little SE; Sodha N; Reis-Filho JS; Mackay A; Fenwick K; Ashworth A; Perlman EJ; Dome JS; Grundy PE; Pritchard-Jones K; Jones C
    J Pathol; 2007 Jan; 211(1):52-9. PubMed ID: 17103382
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome.
    Santos A; Osorio-Almeida L; Baird PN; Silva JM; Boavida MG; Cowell J
    Hum Genet; 1993 Aug; 92(1):83-6. PubMed ID: 8396067
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.
    Call KM; Glaser T; Ito CY; Buckler AJ; Pelletier J; Haber DA; Rose EA; Kral A; Yeger H; Lewis WH
    Cell; 1990 Feb; 60(3):509-20. PubMed ID: 2154335
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Wilms' tumor and ring chromosome 11 in a child].
    Zhang H; Feng C; Tang SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):993-4. PubMed ID: 23234794
    [No Abstract]   [Full Text] [Related]  

  • 65. Molecular basis of Wilms' tumor.
    Grundy P
    Cancer Treat Res; 1997; 92():101-23. PubMed ID: 9494759
    [No Abstract]   [Full Text] [Related]  

  • 66. Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.
    Brandt A; Löhers K; Beier M; Leube B; de Torres C; Mora J; Arora P; Jat PS; Royer-Pokora B
    PLoS One; 2016; 11(5):e0155561. PubMed ID: 27213811
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chromosome 1 studies in Wilms' tumor.
    McDowell H; Howard P; Martin J; Hart C; Crampton J
    Cancer Genet Cytogenet; 1989 Dec; 43(2):203-9. PubMed ID: 2557151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Homozygous intragenic loss of the WT1 locus in a sporadic intralobar Wilms' tumor.
    Radice P; Pilotti S; De Benedetti V; Mondini P; Miozzo M; Luksch R; Fossati Bellani F; Della Porta G; Pierotti MA
    Int J Cancer; 1993 Aug; 55(1):174-6. PubMed ID: 8393841
    [No Abstract]   [Full Text] [Related]  

  • 69. Mapping of human chromosome 11: organization of genes within the Wilms' tumor region of the chromosome.
    Housman DE; Glaser T; Gerhard DS; Jones C; Bruns GA; Lewis WH
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():837-41. PubMed ID: 3034498
    [No Abstract]   [Full Text] [Related]  

  • 70. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development.
    Buckler AJ; Pelletier J; Haber DA; Glaser T; Housman DE
    Mol Cell Biol; 1991 Mar; 11(3):1707-12. PubMed ID: 1671709
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TaqI RFLPs at the Wilms' tumor gene (WT1).
    Tadokoro K; Kato M; Yokota S; Yamada M
    Nucleic Acids Res; 1991 May; 19(9):2514. PubMed ID: 1675003
    [No Abstract]   [Full Text] [Related]  

  • 72. Maternal allele loss in Wilms' tumour.
    Williams JC; Brown KW; Mott MG; Maitland NJ
    Lancet; 1989 Feb; 1(8632):283-4. PubMed ID: 2563452
    [No Abstract]   [Full Text] [Related]  

  • 73. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.
    Berry RL; Ozdemir DD; Aronow B; Lindström NO; Dudnakova T; Thornburn A; Perry P; Baldock R; Armit C; Joshi A; Jeanpierre C; Shan J; Vainio S; Baily J; Brownstein D; Davies J; Hastie ND; Hohenstein P
    Dis Model Mech; 2015 Aug; 8(8):903-17. PubMed ID: 26035382
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The 11p15.5 ribonucleotide reductase M1 subunit locus is not imprinted in Wilms' tumour and hepatoblastoma.
    Byrne JA; Smith PJ
    Hum Genet; 1993 Apr; 91(3):275-7. PubMed ID: 8386696
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Wilms' tumour 1 (WT1) in development, homeostasis and disease.
    Hastie ND
    Development; 2017 Aug; 144(16):2862-2872. PubMed ID: 28811308
    [TBL] [Abstract][Full Text] [Related]  

  • 76. WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences.
    Huff V; Jaffe N; Saunders GF; Strong LC; Villalba F; Ruteshouser EC
    Am J Hum Genet; 1995 Jan; 56(1):84-90. PubMed ID: 7825606
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The genetics of Wilms' tumor.
    Haber DA; Housman DE
    Adv Cancer Res; 1992; 59():41-68. PubMed ID: 1325734
    [No Abstract]   [Full Text] [Related]  

  • 78. Expression of KRT7 and WT1 differentiates precursor lesions of Wilms' tumours from those of papillary renal cell tumours and mucinous tubular and spindle cell carcinomas.
    Szponar A; Kovacs G
    Virchows Arch; 2012 Apr; 460(4):423-7. PubMed ID: 22382985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The QM gene is X-linked and therefore not involved in suppression of tumorigenesis in Wilms' tumor.
    van den Ouweland AM; Verdijk M; Mannens MM; van Oost BA
    Hum Genet; 1992; 90(1-2):144-6. PubMed ID: 1330878
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Constitutional and acquired rearrangements of chromosome 7 in Wilms tumor.
    Rivera H
    Cancer Genet Cytogenet; 1995 May; 81(1):97-8. PubMed ID: 7773968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.